Tdap疫苗接种母亲所生健康儿童的白喉、破伤风及b型流感嗜血杆菌抗体水平
泰国队列研究(NCT02408926)评估孕期接种含破伤风类毒素疫苗或Tdap疫苗母亲所生儿童对白喉类毒素、破伤风类毒素和b型流感嗜血杆菌(Hib)的IgG应答。基础免疫和加强免疫后,抗DT、抗TT和抗Hib血清保护率分别>90%和>99%;五价疫苗诱导的抗Hib IgG高于六价疫苗,且TT接种母亲所生儿童抗Hib IgG更高。孕期接种未损害基础或加强免疫后的血清保护率。
要点
- 基础免疫后抗DT、抗TT和抗Hib血清保护率>90%,加强后>99%。
- 五价疫苗诱导的抗Hib IgG高于六价疫苗。
- TT接种母亲所生儿童抗Hib IgG高于Tdap接种母亲所生儿童。
核心结论
- 孕期接种含TT疫苗或Tdap疫苗未损害儿童基础及加强免疫后的血清保护率。
研究设计与样本
- 泰国儿童队列研究(ClinicalTrial.gov NCT02408926),母亲孕期接种含TT疫苗和/或Tdap疫苗。
- Tdap接种母亲所生儿童随机接受六价(Infanrix-hexa)或五价(Quinvaxem)疫苗,TT接种母亲所生儿童仅接受五价疫苗,于2、4、6、18月龄接种。
- 采用酶联免疫法检测出生(脐血)、2、7、18、19月龄IgG水平。
主要发现
- 基础免疫后抗DT、抗TT和抗Hib血清保护浓度在>90%儿童中达到。
- 加强免疫后抗DT、抗TT和抗Hib血清保护浓度在>99%儿童中达到。
- Tdap接种母亲所生儿童中,五价疫苗诱导的抗Hib IgG在基础免疫和加强免疫后均高于六价疫苗。
- TT接种母亲所生儿童接受五价疫苗后,抗Hib IgG在基础免疫和加强免疫后均显著高于Tdap接种母亲所生儿童接受五价疫苗者。
临床怎么用
- 孕期接种含TT疫苗或Tdap疫苗不降低儿童后续基础及加强免疫的血清保护率。
- 选择五价疫苗可能获得更高抗Hib IgG水平,尤其TT接种母亲所生儿童。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Vaccination of pregnant women protects both women and their newborns against some infectious diseases. Thailand implemented tetanus toxoid (TT) vaccination of pregnant women in 1977, which was replaced by tetanus-diphtheria toxoid (dT) vaccination in 2005. The tetanus-diphtheria-acellular pertussis (Tdap) vaccine has been recommended for pregnant women at 27-36 weeks of gestation since 2012 in several countries. Data on antibody responses to diphtheria toxoid (DT), TT, and Hemophilus influenzae type b (Hib) induced by combined vaccines in children born to TT-vaccinated and/or Tdap-vaccinated mothers are limited. MATERIAL AND METHODS: We investigated anti-DT, anti-TT, and anti-Hib IgG responses in a cohort of Thai children (ClinicalTrial.gov NCT02408926) born to mothers who received a TT-containing and/or the Tdap vaccine during pregnancy. Children born to Tdap-vaccinated mothers were randomized to receive either a hexavalent (Infanrix-hexa) or pentavalent (Quinvaxem) vaccine, whereas children born to TT-vaccinated mothers received only Quinvaxem vaccine at 2, 4, 6, and 18 months of age. IgG levels were evaluated at birth (cord blood), 2 (pre-primary), 7 (post-primary), 18 (pre-booster), and 19 months of age (post-booster) using a commercially available enzyme-linked immunoassay. RESULTS: Seroprotective concentrations of anti-DT, anti-TT, and anti-Hib IgG were achieved in >90% and >99% of children following primary and booster vaccination, respectively. Among children born to Tdap-vaccinated mothers, the pentavalent vaccine induced higher levels of anti-Hib IgG than the hexavalent vaccine after primary and booster vaccination. Significantly higher anti-Hib IgG levels were observed among children receiving the pentavalent vaccine and who were born to TT-vaccinated mothers than among children receiving the pentavalent vaccine and born to Tdap-vaccinated mothers after primary and booster vaccination. CONCLUSIONS: Vaccination with a TT-containing and/or the Tdap vaccine during pregnancy did not compromise the seroprotection rate achieved following primary and booster immunization in individuals receiving either the pentavalent or hexavalent vaccine.
引用
- Wanlapakorn N, Maertens K, Thongmee T, et al. Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers. Vaccine. 2020. PMID: 32888740. doi:10.1016/j.vaccine.2020.08.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。